Latest Breaking News On - Annual congress - Page 1 : vimarsana.com

foundry-planet.com - B2B Portal: 7 reasons to come to Metal China 2024

7 reasons to come to Metal China 2024

Investigational Antipsychotic Demonstrates Efficacy Without Blocking Dopamine Receptor

Investigational agent KarXT is a first-in-class muscarinic receptor agonist demonstrating antipsychotic efficacy and safety in short- and long-term clinical trials.

New Post-Hoc Analysis of Pooled Phase 3 Data Shows That Inpefa (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction

Analysis adds to the body of evidence differentiating INPEFA as a dual oral inhibitor of SGLT2 and SGLT1

Sanofi: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3

ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3 Sarclisa, in combination

Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3

Impact investments: An emerging asset class - The Zimbabwe Independent

Diverse sectors - Impact investing can span various sectors such as clean energy, affordable housing, healthcare, education, sustainable agriculture;

Ionis presents positive results from OASIS-HAE and OASISplus studies of investigational medicine donidalorsen in patients with hereditary angioedema

Donidalorsen delivered significant and sustained reductions in HAE attacks, with high levels of disease control and improvement in quality of life measures with monthly or every two-month dosing;...

GENFIT to Present Latest ACLF Research at EASL Congress™ 2024

Lille , Cambridge , Zurich , May 29, 2024 - GENFIT , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today detailed...

GENFIT to Present Latest ACLF Research at EASL Congress™

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 29, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage...

Human Rights Group Marches in Protest to Demand RANZCP End Dangerous Coercive Psychiatric Practices as Advised by the World Health Organization and the UN | National News